Literature DB >> 10420196

Visual impairment and REP-1 gene mutations in Japanese choroideremia patients.

M Hayakawa1, K Fujiki, Y Hotta, R Ito, J Ohki, J Ono, A Saito, K Nakayasu, A Kanai, K Ishidoh, E Kominami, K Yoshida, K C Kim, H Ohashi.   

Abstract

Choroideremia (CHM), an X-linked recessive hereditary disease, is an intractable chorioretinal dystrophy. The rate of disease progression of CHM reportedly shows considerable variability. A number of mutations involving the gene that codes for Rab escort protein-1 (REP-1) have been detected in CHM patients. We have analyzed REP-1 gene mutations of Japanese CHM patients. The present study was designed to investigate the clinical variability and the genotype to phenotype relationship in 15 Japanese CHM patients referred to the Department of Ophthalmology of Juntendo University Hospital. The clinical investigation of visual acuity, visual field, color vision and refraction revealed inter-individual variability. Mutation analyses of the REP-1 gene revealed 10 types of mutations in 13 patients from 11 families, including an insertion, small deletions, nonsense mutations and an A to CC mutation. In 13 CHM patients with detectable REP-1 gene mutations, no relationship of genotype to phenotype was detected. At present, we consider the REP-1 genotype to be an unreliable prognostic factor for counseling of CHM patients. In two patients from one family, no mutations were detected in coding regions of the REP-1 gene. These patients may have intron mutations of the REP-1 gene, not detectable by the techniques employed in this study, or other causative genes. Both were observed to have somewhat slower disease progression than the other 13 patients. More advanced analyses are necessary to answer questions regarding the genotype-phenotype relationship in CHM patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10420196     DOI: 10.1076/opge.20.2.107.2285

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  12 in total

1.  Colour discrimination ellipses in choroideremia.

Authors:  Immanuel P Seitz; Jasleen K Jolly; M Dominik Fischer; Matthew P Simunovic
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-05       Impact factor: 3.117

2.  Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study.

Authors:  Tomas S Aleman; Grace Han; Leona W Serrano; Nicole M Fuerst; Emily S Charlson; Denise J Pearson; Daniel C Chung; Anastasia Traband; Wei Pan; Gui-Shuang Ying; Jean Bennett; Albert M Maguire; Jessica I W Morgan
Journal:  Ophthalmology       Date:  2016-12-13       Impact factor: 12.079

3.  Choroideremia in a woman with ectodermal dysplasia and complex translocations involving chromosomes X, 1, and 3.

Authors:  Krishna Mukkamala; Ronald C Gentile; Judith Willner; Stephen Tsang
Journal:  Ophthalmic Genet       Date:  2010-12       Impact factor: 1.803

4.  Clinical characteristics of a large choroideremia pedigree carrying a novel CHM mutation.

Authors:  Alex S Huang; Leo A Kim; Amani A Fawzi
Journal:  Arch Ophthalmol       Date:  2012-09

5.  A novel mutation (967-970+2)delAAAGGT in the choroideremia gene found in a Japanese family and related clinical findings.

Authors:  Yutaka Iino; Takuro Fujimaki; Keiko Fujiki; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2008-09-05       Impact factor: 2.447

6.  Long-term natural history of visual acuity in eyes with choroideremia: a systematic review and meta-analysis of data from 1004 individual eyes.

Authors:  Liangbo L Shen; Aneesha Ahluwalia; Mengyuan Sun; Benjamin K Young; Holly K Grossetta Nardini; Lucian V Del Priore
Journal:  Br J Ophthalmol       Date:  2020-05-29       Impact factor: 5.908

7.  The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype.

Authors:  Matthew P Simunovic; Jasleen K Jolly; Kanmin Xue; Thomas L Edwards; Markus Groppe; Susan M Downes; Robert E MacLaren
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-11-01       Impact factor: 4.799

8.  Comparing Clinical Perimetry and Population Receptive Field Measures in Patients with Choroideremia.

Authors:  Edward H Silson; Tomas S Aleman; Aimee Willett; Leona W Serrano; Denise J Pearson; Andreas M Rauschecker; Albert M Maguire; Chris I Baker; Jean Bennett; Manzar Ashtari
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-07-02       Impact factor: 4.799

9.  Longitudinal Study to Assess the Quantitative Use of Fundus Autofluorescence for Monitoring Disease Progression in Choroideremia.

Authors:  Adam M Dubis; Wei S Lim; Jasleen K Jolly; Maria Toms; Robert E MacLaren; Andrew R Webster; Mariya Moosajee
Journal:  J Clin Med       Date:  2021-01-11       Impact factor: 4.241

10.  Genetic defects of CHM and visual acuity outcome in 24 choroideremia patients from 16 Japanese families.

Authors:  Takaaki Hayashi; Shuhei Kameya; Kei Mizobuchi; Daiki Kubota; Sachiko Kikuchi; Kazutoshi Yoshitake; Atsushi Mizota; Akira Murakami; Takeshi Iwata; Tadashi Nakano
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.